Skip to main content

Table 1 MDS patients’ characteristics

From: TET2 is upregulated during erythroid differentiation of CD34+ cells from healthy donors and myelodysplastic syndrome patients

Factors

Number

Gender, n (%)

 Male

6

 Female

1

Age y, median (range)

67 (36–75)

Bone marrow blasts (%), median (range)

2.5 (0–4.5)

WHO 2008

 RCMD/RARS

6/1

Karyotype, n

 Normal

7

Peripheral blood counts, median (range)

 Hemoglobin, g/dL

12.8 (7.0–14.2)

 Neutrophils, ×109/L

1.1 (0.2–1.7)

 Platelet count, ×109/L

112 (39–259)

  1. Abbreviations: MDS, myelodysplastic syndromes; WHO, World Health Organization; RCMD, refractory cytopenia with multilineage dysplasia; RARS, refractory anemia with ringed sideroblasts
Back to article page

Applied Cancer Research

ISSN: 1980-5578